Cargando…
Functional assays to screen and select monoclonal antibodies that target Yersinia pestis
Yersinia pestis is a gram-negative bacterium that causes plague in animals and humans. Depending on the route of disease transmission, the bacterium can cause an acute, often fatal disease that has a narrow window for treatment with antibiotics. Additionally, antibiotic resistant strains have been i...
Autores principales: | Biryukov, Sergei S., Rill, Nathaniel O., Klimko, Christopher P., Dankmeyer, Jennifer L., Shoe, Jennifer L., Hunter, Melissa, Talyansky, Yuli, Hau, Derrick, Gates-Hollingsworth, Marcellene A., Pandit, Sujata G., Fetterer, David P., Qiu, Ju, Davies, Michael L., AuCoin, David P., Cote, Christopher K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332183/ https://www.ncbi.nlm.nih.gov/pubmed/37289480 http://dx.doi.org/10.1080/21645515.2023.2216085 |
Ejemplares similares
-
Protection Elicited by Attenuated Live Yersinia pestis Vaccine Strains against Lethal Infection with Virulent Y. pestis
por: Cote, Christopher K., et al.
Publicado: (2021) -
The Use of Analgesics during Vaccination with a Live Attenuated Yersinia pestis Vaccine Alters the Resulting Immune Response in Mice
por: Culbreth, Marilynn J., et al.
Publicado: (2019) -
Impact of Toll-Like Receptor-Specific Agonists on the Host Immune Response to the Yersinia pestis Plague rF1V Vaccine
por: Biryukov, Sergei, et al.
Publicado: (2021) -
Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29–34 wGA) infants without outpatient palivizumab administration
por: Packnett, Elizabeth R., et al.
Publicado: (2023) -
Layered and integrated medical countermeasures against Burkholderia pseudomallei infections in C57BL/6 mice
por: Klimko, Christopher P., et al.
Publicado: (2022)